Sellas Life Sciences
SLS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Sellas Life Sciences(SLS) predict that the EBIT is -9.252 M (-52.6%), Miss estimate;the EPS is -0.05 (+28.57%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B52.60%
-0.01B48.74%
-0.00B3.86%
EPSExceed expectations
-0.0528.57%
-0.0614.29%
+0.010014.28%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf